Leading analyst gives InterCure overweight rating, noting 5x returns potential

InterCure Ltd. (NASDAQ: INCR), a prominent player in the global medical cannabis industry, has received an Overweight rating from Zuanic & Associates, a highly respected firm, which are widely considered leading the field of cannabis and psychedelics.